Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2013 1
2016 1
2017 2
2020 1
2021 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Dujardin S, et al. Among authors: elwood f. Nat Med. 2020 Aug;26(8):1256-1263. doi: 10.1038/s41591-020-0938-9. Epub 2020 Jun 22. Nat Med. 2020. PMID: 32572268 Free PMC article.
A proteogenomic view of Parkinson's disease causality and heterogeneity.
Kaiser S, Zhang L, Mollenhauer B, Jacob J, Longerich S, Del-Aguila J, Marcus J, Raghavan N, Stone D, Fagboyegun O, Galasko D, Dakna M, Bilican B, Dovlatyan M, Kostikova A, Li J, Peterson B, Rotte M, Sanz V, Foroud T, Hutten SJ, Frasier M, Iwaki H, Singleton A, Marek K, Crawford K, Elwood F, Messa M, Serrano-Fernandez P. Kaiser S, et al. Among authors: elwood f. NPJ Parkinsons Dis. 2023 Feb 11;9(1):24. doi: 10.1038/s41531-023-00461-9. NPJ Parkinsons Dis. 2023. PMID: 36774388 Free PMC article.
Vesicle trafficking and pathways to neurodegeneration.
Blackstone C, Elwood F, Plun-Favreau H, Lewis PA. Blackstone C, et al. Among authors: elwood f. Mol Neurodegener. 2021 Aug 21;16(1):56. doi: 10.1186/s13024-021-00480-1. Mol Neurodegener. 2021. PMID: 34419119 Free PMC article. No abstract available.
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy.
Nasir G, Chopra R, Elwood F, Ahmed SS. Nasir G, et al. Among authors: elwood f. Front Med (Lausanne). 2021 Nov 11;8:760236. doi: 10.3389/fmed.2021.760236. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869463 Free PMC article. Review.
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons.
Sanchez CG, Acker CM, Gray A, Varadarajan M, Song C, Cochran NR, Paula S, Lindeman A, An S, McAllister G, Alford J, Reece-Hoyes J, Russ C, Craig L, Capre K, Doherty C, Hoffman GR, Luchansky SJ, Polydoro M, Dolmetsch R, Elwood F. Sanchez CG, et al. Among authors: elwood f. Commun Biol. 2021 Jun 14;4(1):736. doi: 10.1038/s42003-021-02272-1. Commun Biol. 2021. PMID: 34127790 Free PMC article.
Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Dujardin S, et al. Among authors: elwood f. Nat Med. 2021 Feb;27(2):356. doi: 10.1038/s41591-021-01251-7. Nat Med. 2021. PMID: 33514949 Free PMC article. No abstract available.
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.
Luo J, Elwood F, Britschgi M, Villeda S, Zhang H, Ding Z, Zhu L, Alabsi H, Getachew R, Narasimhan R, Wabl R, Fainberg N, James ML, Wong G, Relton J, Gambhir SS, Pollard JW, Wyss-Coray T. Luo J, et al. Among authors: elwood f. J Exp Med. 2013 Jan 14;210(1):157-72. doi: 10.1084/jem.20120412. Epub 2013 Jan 7. J Exp Med. 2013. PMID: 23296467 Free PMC article.
Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor.
Elwood F, Witter DJ, Piesvaux J, Kraybill B, Bays N, Alpert C, Goldenblatt P, Qu Y, Ivanovska I, Lee HH, Chiu CS, Tang H, Scott ME, Deshmukh SV, Zielstorff M, Byford A, Chakravarthy K, Dorosh L, Rivkin A, Klappenbach J, Pan BS, Kariv I, Dinsmore C, Slipetz D, Dandliker PJ. Elwood F, et al. J Pharmacol Exp Ther. 2017 May;361(2):229-244. doi: 10.1124/jpet.116.239723. Epub 2017 Feb 13. J Pharmacol Exp Ther. 2017. PMID: 28193636
The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties.
Siu T, Brubaker J, Fuller P, Torres L, Zeng H, Close J, Mampreian DM, Shi F, Liu D, Fradera X, Johnson K, Bays N, Kadic E, He F, Goldenblatt P, Shaffer L, Patel SB, Lesburg CA, Alpert C, Dorosh L, Deshmukh SV, Yu H, Klappenbach J, Elwood F, Dinsmore CJ, Fernandez R, Moy L, Young JR. Siu T, et al. Among authors: elwood f. J Med Chem. 2017 Dec 14;60(23):9676-9690. doi: 10.1021/acs.jmedchem.7b01135. Epub 2017 Dec 4. J Med Chem. 2017. PMID: 29156136
11 results